Cargando…

Skin-antigen specific antibodies are detected in UV irradiation and TLR7 agonist induced lupus-like disease in autoimmune prone NOD mice and in pediatric SLE

Detalles Bibliográficos
Autores principales:	Ghoreishi, M, Tucker, L, Dutz, JP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467520/ http://dx.doi.org/10.1186/ar3977

Ejemplares similares

A role for cutaneous gamma delta T cells in the development of systemic lupus erythematosus
por: Ghoreishi, Mehran, et al.
Publicado: (2014)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7 variant
por: Deng, Y, et al.
Publicado: (2012)

Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
por: Yariwake, Victor Yuji, et al.
Publicado: (2021)

Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002)

Immuno-serological profile of Systemic Erythemic Lupus (SLE) patients with neuropsychiatric manifestations (NP)
por: Stojanovich, L, et al.
Publicado: (2001)

Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone mice
por: Maria, Naomi I, et al.
Publicado: (2023)

Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice
por: Chu, Seung Y., et al.
Publicado: (2020)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

Connecting the molecular dots from inaccessible antigen to organ injury in the pathogenesis of cardiac manifestations of neonatal lupus
por: Buyon, JP
Publicado: (2012)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice
por: Edwards, Michael R., et al.
Publicado: (2020)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022)

The role of DNA in the pathogenesis of SLE
por: Pisetsky, DS
Publicado: (2001)

Death receptor 6 contributes to autoimmunity in lupus-prone mice
por: Fujikura, Daisuke, et al.
Publicado: (2017)

Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen
por: Lee, Michael H., et al.
Publicado: (2018)

Long-term retention of non-funcionalized carbon nanotubes in nod mice and its influence on the evolution of autoimmune diabetes
por: da Silva Camilo, Daniela, et al.
Publicado: (2015)

Innate Immune Receptors in Human Airway Smooth Muscle Cells: Activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 Agonists
por: Månsson Kvarnhammar, Anne, et al.
Publicado: (2013)

Genetic analysis of the pentraxin genes in SLE
por: Russell, AI, et al.
Publicado: (2001)

Phenotypic consequences of TLR7-driven interferon and proinflammatory cytokine production in lupus
por: Reeves, Westley H, et al.
Publicado: (2014)

Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.
por: Pollard, K M, et al.
Publicado: (2001)

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

SLE risk alleles and cell development and activation
por: Kim, SJ, et al.
Publicado: (2012)

SLE: insights from array-based proteomics
por: Wu, T, et al.
Publicado: (2012)

Clinical impact of biologic therapy in the treatment of SLE
por: Wallace, Daniel J
Publicado: (2013)

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses
por: Gutjahr, Alice, et al.
Publicado: (2020)

Novel chimeric TLR2/NOD2 agonist CL429 exhibited significant radioprotective effects in mice
por: Cheng, Ying, et al.
Publicado: (2021)

Dietary fat differentially modulates the response of bone marrow-derived macrophages to TLR4 and NOD2 agonists
por: Shehat, Michael G., et al.
Publicado: (2023)

Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity.
por: Pollard, K M, et al.
Publicado: (1999)

Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption
por: Bates, Melissa A., et al.
Publicado: (2016)

Signalling via T cell receptor (TCR) in patients with SLE
por: Cebecauer, M, et al.
Publicado: (2001)

Neuropsychiatric events in SLE: determination of attribution and assessment of outcome
por: Hanly, JG
Publicado: (2012)

PROMISSE: progress in understanding pregnancy complications in patients with SLE
por: Salmon, JE
Publicado: (2012)

Mechanisms of B cell autoimmunity in SLE
por: Dörner, Thomas, et al.
Publicado: (2011)

Autoimmune Thrombocytopenia in SLE and COVID-19
por: Pratama, Yeremia Suryo, et al.
Publicado: (2021)

Warm Autoimmune Hemolytic Anemia as the Initial Presentation of Systemic Lupus Erythematosus (SLE): A Case Report
por: Kander, Tejaswi, et al.
Publicado: (2021)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

Malignancy in Systemic Lupus Erythematosus (SLE) Patients
por: Cader, Rizna Abdul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4pr5ggife3nln0jqh28j6vvvfu